Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Frequency ExchangeFRECF 8 Days Sales Outstanding is 5.12 as of Mar. 2026, which is 96% above its 10-year median of 2.61. GuruFocus rates FRECF with a GF Score™ of 8/100 and a GF Value™ of $0.09 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 811 Medical Devices & Instruments companies, Frequency Exchange ranks better than 97.04% on this metric.
The historical rank and industry rank for Frequency Exchange's Days Sales Outstanding or its related term are showing as below:
FRECF'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 1.76 Med: 2.61 Max: 15.97
Current: 15.97
During the past 6 years, Frequency Exchange's highest Days Sales Outstanding was 15.97. The lowest was 1.76. And the median was 2.61.
FRECF's Days Sales Outstanding is ranked better than 97.04% of 811
companies
in the Medical Devices & Instruments industry
Industry Median: 66.27
vs FRECF: 15.97
Frequency Exchange's Days Sales Outstanding
declined
from Mar. 2025 (10.69) to Mar. 2026 (5.12).
Frequency Exchange (OTCPK:FRECF) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Frequency Exchange Days Sales Outstanding Related Terms
Frequency Exchange Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for Frequency Exchange's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRECF vs ABT, SYK, MDT: Days Sales Outstanding Comparison
For the Medical Devices subindustry, Frequency Exchange's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Frequency Exchange Days Sales Outstanding vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Frequency Exchange's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Frequency Exchange's Days Sales Outstanding falls into.
Frequency Exchange Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Frequency Exchange (FRECF) has a Days Sales Outstanding of 5.12 as of Mar. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Frequency Exchange and its competitors. This is 96% above median its historical median of 2.61. Over the past decade, Frequency Exchange's Days Sales Outstanding has ranged from 1.76 to 15.97. According to the industry distribution chart, Frequency Exchange ranks #24 out of 811 companies in the Medical Devices & Instruments industry, placing it in the top 3%.
Is Frequency Exchange's Days Sales Outstanding too high?
Frequency Exchange's current Days Sales Outstanding of 5.12 is 96% above median its 10-year median of 2.61. Over the past 10 years, this metric has ranged from a low of 1.76 to a high of 15.97. The Medical Devices & Instruments industry median Days Sales Outstanding is 66.27. Frequency Exchange's value of 5.12 is 92.3% below this industry median. Based on the distribution chart, Frequency Exchange ranks #24 out of 811 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Frequency Exchange has a GF Score™ of 8/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Frequency Exchange's Days Sales Outstanding compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Frequency Exchange ranks #24 out of 811 companies for Days Sales Outstanding. This places Frequency Exchange in the top 3% of its industry — outperforming the majority of peers. The industry median Days Sales Outstanding is 66.27. Frequency Exchange's value of 5.12 is 92.3% below this benchmark. Historically, Frequency Exchange's own Days Sales Outstanding has ranged from 1.76 to 15.97 over the past decade. While the company's 10-year median is 2.61 vs. the industry median of 66.27, Frequency Exchange has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Medical Devices & Instruments company?
The median Days Sales Outstanding among Medical Devices & Instruments companies is 66.27, based on 811 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Frequency Exchange's current Days Sales Outstanding of 5.12 is 92.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Frequency Exchange and its competitors. For the Medical Devices & Instruments industry, the median Days Sales Outstanding is 66.27 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Frequency Exchange's current Days Sales Outstanding is 5.12, which is 96% above median its own 10-year median of 2.61. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Frequency Exchange stock overvalued right now?
Based on GuruFocus' analysis, Frequency Exchange (FRECF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.09, compared to a current price of $0.20 — trading 119% above its estimated fair value. The current Days Sales Outstanding is 5.12, which is 96% above median its 10-year median of 2.61 and 92.3% below the Medical Devices & Instruments industry median of 66.27. Frequency Exchange's overall GF Score™ is 8/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Frequency Exchange (FRECF), the current Days Sales Outstanding is 5.12 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Frequency Exchange (FRECF) Overvalued in 2026?
Based on GuruFocus' analysis, Frequency Exchange stock appears to be overvalued.
The current stock price of $0.20 is trading 119% above its estimated GF Value™ of $0.09.
GuruFocus considers Frequency Exchange to be Significantly Overvalued.
Key valuation signals for FRECF:
Days Sales Outstanding: 5.12 (96% above median its 10-year median of 2.61)
GF Value™: $0.09 vs. price of $0.20 (119% above fair value)
Industry Position: 92.3% below the Medical Devices & Instruments median (#24 of 811)
No single metric tells the full story. See the FRECF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Frequency Exchange Corp is focused on the development and world-wide commercialization of a wearable Frequency Delivery System providing specialized programs designed for health and wellness as well as performance enhancement. The company has one operating and reportable segment which the sale of wearable devices. Geographically, it operates in Canada; United States; and International.
8GF Score
Get the complete analysis for FRECF
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRECF has been successfully added to your 
